Literature DB >> 8827773

Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity.

S Kotecha1, L Wilson, A Wangoo, M Silverman, R J Shaw.   

Abstract

Chronic lung disease (CLD) of prematurity is associated with an initial increase in pulmonary neutrophils followed by pulmonary fibrosis. We determined whether the proinflammatory cytokines, IL-1 beta and IL-6, were increased in the bronchoalveolar lavage fluid obtained from nine infants (median gestation 25 wk, birthweight 820 g) who developed CLD, seven (28 wk, 1110 g) who recovered from the respiratory distress syndrome (RDS), and four (38 wk, 2690 g) control infants. IL-1 beta and IL-6 protein were both increased in the bronchoalveolar lavage fluid from the CLD groups when compared with the RDS and control groups. This difference for both the cytokines was most marked on d 10 of age, when results from infants with and without CLD were compared (IL-1 beta, 4.6 versus 1.1 ng/mL, p < 0.05; and IL-6, 9.5 versus 1.5 ng/mL, p < 0.05). Immunocytochemistry of lavage cells for IL-1 beta, IL-6, and IL-8 protein showed alveolar macrophages to contain all three cytokines, with lesser staining evident in neutrophils, and in epithelial cells occasionally obtained by lavage. The contribution of alveolar macrophages and luminal cells to the increase in IL-6 and IL-1 was determined by performing semiquantitative reverse transcription-polymerase chain reactions on RNA extracted from lavage cells. IL-6 mRNA expression was increased in lavage cells from the CLD infants when compared with the RDS group. However, the expression for IL-1 beta and IL-8 mRNA was similar in both groups. These results suggest that IL-1 beta, IL-6, and IL-8 may contribute to the pathogenesis of CLD, and that, in CLD, IL-6 may be produced by cells within the air spaces.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827773     DOI: 10.1203/00006450-199608000-00010

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  60 in total

1.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.

Authors:  M Kolb; P J Margetts; D C Anthony; F Pitossi; J Gauldie
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

3.  Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia.

Authors:  Soumyaroop Bhattacharya; Diana Go; Daria L Krenitsky; Heidi L Huyck; Siva Kumar Solleti; Valerie A Lunger; Leon Metlay; Sorachai Srisuma; Susan E Wert; Thomas J Mariani; Gloria S Pryhuber
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

4.  Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant?

Authors:  A E Harling; M W Beresford; G S Vince; M Bates; C W Yoxall
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-29       Impact factor: 5.747

Review 5.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

Review 6.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

7.  Clara cell secretory protein (CC16) as a peripheral blood biomarker of lung injury in ventilated preterm neonates.

Authors:  Kosmas Sarafidis; Theodora Stathopoulou; Elisavet Diamanti; Vasiliki Soubasi; Charalambos Agakidis; Aikaterini Balaska; Vasiliki Drossou
Journal:  Eur J Pediatr       Date:  2008-06-03       Impact factor: 3.183

8.  Safety and efficacy of nitric oxide in chronic lung disease.

Authors:  P L Clark; I I Ekekezie; H A Kaftan; C A Castor; W E Truog
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

9.  Influence of sex and disease severity on gene expression profiles in individuals with idiopathic pulmonary fibrosis.

Authors:  Sean P McGee; Hongmei Zhang; Wilfried Karmaus; Tara Sabo-Attwood
Journal:  Int J Mol Epidemiol Genet       Date:  2014-05-29

10.  The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.

Authors:  Jie Liao; Vishal S Kapadia; L Steven Brown; Naeun Cheong; Christopher Longoria; Dan Mija; Mrithyunjay Ramgopal; Julie Mirpuri; Donald C McCurnin; Rashmin C Savani
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.